- Home
- ZVSA vs ICON Comparison
ZVSA vs ICON Comparison
Compare ZVSA & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- ICON
- Stock Information
- Founded
- ZVSA 2014
- ICON 2023
- Country
- ZVSA United States
- ICON Greece
- Employees
- ZVSA N/A
- ICON N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- ICON
- Sector
- ZVSA Health Care
- ICON
- Exchange
- ZVSA Nasdaq
- ICON Nasdaq
- Market Cap
- ZVSA 3.5M
- ICON 3.6M
- IPO Year
- ZVSA N/A
- ICON 2024
- Fundamental
- Price
- ZVSA $0.59
- ICON $2.17
- Analyst Decision
- ZVSA Strong Buy
- ICON Strong Buy
- Analyst Count
- ZVSA 1
- ICON 1
- Target Price
- ZVSA $240.00
- ICON $280.00
- AVG Volume (30 Days)
- ZVSA 125.6K
- ICON 850.7K
- Earning Date
- ZVSA 05-14-2025
- ICON 05-15-2025
- Dividend Yield
- ZVSA N/A
- ICON 0.19%
- EPS Growth
- ZVSA N/A
- ICON N/A
- EPS
- ZVSA N/A
- ICON 12.11
- Revenue
- ZVSA N/A
- ICON $4,810,000.00
- Revenue This Year
- ZVSA N/A
- ICON $32.17
- Revenue Next Year
- ZVSA N/A
- ICON $58.62
- P/E Ratio
- ZVSA N/A
- ICON $0.18
- Revenue Growth
- ZVSA N/A
- ICON 5.71
- 52 Week Low
- ZVSA $0.58
- ICON $1.60
- 52 Week High
- ZVSA $8.05
- ICON $154.00
- Technical
- Relative Strength Index (RSI)
- ZVSA 27.23
- ICON N/A
- Support Level
- ZVSA $0.69
- ICON N/A
- Resistance Level
- ZVSA $0.65
- ICON N/A
- Average True Range (ATR)
- ZVSA 0.06
- ICON 0.00
- MACD
- ZVSA -0.00
- ICON 0.00
- Stochastic Oscillator
- ZVSA 3.04
- ICON 0.00
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.